A Phase III Study to Evaluate the Efficacy and Safety of APL-2 in Patients With PNH

Case Medical Research ◽

10.31525/ct1-nct04085601 ◽

2019 ◽

Author(s):

Keyword(s):

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Study

Download Full-text

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Case Medical Research ◽

10.31525/ct1-nct04033354 ◽

2019 ◽

Author(s):

Keyword(s):

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Case Medical Research ◽

10.31525/ct1-nct04063163 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Extensive Stage

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718340215.793493941 ◽

2014 ◽

Author(s):

Kamran Ghoreschi ◽

Sebastian Volc

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Faculty Opinions recommendation of Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718874797.793499746 ◽

2014 ◽

Author(s):

Mark Levis

Keyword(s):

At Risk ◽

Uric Acid ◽

Tumor Lysis Syndrome ◽

Phase Iii ◽

Efficacy And Safety ◽

Tumor Lysis ◽

Plasma Uric Acid ◽

Multicenter Phase ◽

Phase Iii Study

Download Full-text

Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab‐refractory follicular lymphoma patients in the GADOLIN phase III study

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13974 ◽

2019 ◽

Vol 85 (9) ◽

pp. 1935-1945 ◽

Author(s):

Ekaterina Gibiansky ◽

Leonid Gibiansky ◽

Vincent Buchheit ◽

Nicolas Frey ◽

Michael Brewster ◽

...

Keyword(s):

Follicular Lymphoma ◽

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Study

Download Full-text

A phase III study to compare the efficacy and safety of paclitaxel versus irinotecan in patients with metastatic or recurrent gastric cancer who failed in first-line therapy (KCSG ST10-01)

Annals of Oncology ◽

10.1093/annonc/mdy282.064 ◽

2018 ◽

Vol 29 ◽

pp. viii228-viii229

Author(s):

K.-W. Lee ◽

C.H. Maeng ◽

T.-Y. Kim ◽

D.Y. Zang ◽

Y.H. Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line Therapy ◽

Line Therapy ◽

Recurrent Gastric Cancer ◽

Phase Iii Study

Download Full-text

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)

Gastric Cancer ◽

10.1007/s10120-011-0009-5 ◽

2011 ◽

Vol 14 (1) ◽

pp. 72-80 ◽

Author(s):

Hiroyuki Narahara ◽

Hiroyasu Iishi ◽

Hiroshi Imamura ◽

Akira Tsuburaya ◽

Keisho Chin ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

Cancer Study ◽

Gastric Cancer Study ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

Comparison of the Efficacy and Safety Profiles of a Pelubi Sustained Release Tab Versus a Pelubi Tab in Patients with Chronic Back Pain: A Randomized, Double-Blind, Multi-Institution Phase III Study

Journal of Korean Society of Spine Surgery ◽

10.4184/jkss.2016.23.2.92 ◽

2016 ◽

Vol 23 (2) ◽

pp. 84

Author(s):

Ki Taek Kim ◽

Tae Kyun Kim ◽

Ji Woong Choi ◽

Jae Sung Ahn ◽

Young Do Koh ◽

...

Keyword(s):

Back Pain ◽

Sustained Release ◽

Chronic Back Pain ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study

Acta Ophthalmologica ◽

10.1111/j.1755-3768.2010.01862.x ◽

2010 ◽

Vol 88 (1) ◽

pp. 12-19 ◽

Author(s):

Hannu Uusitalo ◽

Lutz E Pillunat ◽

Auli Ropo ◽

Keyword(s):

Ocular Hypertension ◽

Open Angle Glaucoma ◽

Phase Iii ◽

Eye Drops ◽

Efficacy And Safety ◽

Phase Iii Study

Download Full-text

Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2014.01.897 ◽

2014 ◽

Vol 71 (3) ◽

pp. 484-492 ◽

Author(s):

D.S. Krupashankar ◽

Sunil Dogra ◽

Mahendra Kura ◽

Abir Saraswat ◽

Leelavathy Budamakuntla ◽

...

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Double Blind ◽

Phase Iii Study

Download Full-text